Your browser doesn't support javascript.
loading
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.
Ruel, Theodore D; Acosta, Edward P; Liu, Jessica P; Gray, Kathryn P; George, Kathleen; Montañez, Nicole; Popson, Stephanie; Buchanan, Ann M; Bartlett, Mattie; Dayton, Dale; Anthony, Patricia; Brothers, Cynthia; Vavro, Cynthia; Singh, Rajendra; Koech, Lucy; Vhembo, Tichaona; Mmbaga, Blandina T; Pinto, Jorge A; Dobbels, Els F M; Archary, Moherndran; Chokephaibulkit, Kulkanya; Ounchanum, Pradthana; Deville, Jaime G; Hazra, Rohan; Townley, Ellen; Wiznia, Andrew.
Afiliação
  • Ruel TD; University of California, San Francisco, San Francisco, CA, USA. Electronic address: theodore.ruel@ucsf.edu.
  • Acosta EP; University of Alabama at Birmingham, Birmingham, AL, USA.
  • Liu JP; Frontier Science & Technology and Research Foundation, Brookline, MA, USA.
  • Gray KP; Frontier Science & Technology and Research Foundation, Brookline, MA, USA; Harvard T H Chan School of Public Health, Boston, MA, USA.
  • George K; FHI 360, Durham, NC, USA.
  • Montañez N; FHI 360, Durham, NC, USA.
  • Popson S; Frontier Science & Technology and Research Foundation, Amherst, NY, USA.
  • Buchanan AM; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Bartlett M; Frontier Science & Technology and Research Foundation, Amherst, NY, USA.
  • Dayton D; University of California, Los Angeles, Los Angeles, CA, USA.
  • Anthony P; University of Southern California, Los Angeles, CA, USA.
  • Brothers C; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Vavro C; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Singh R; GlaxoSmithKline, Collegeville, PA, USA.
  • Koech L; Kenya Medical Research Institute-Walter Reed Project, Kericho, Kenya.
  • Vhembo T; University of Zimbabwe, Clinical Trials Research Centre, Harare, Zimbabwe.
  • Mmbaga BT; Kilimanjaro Christian Medical Center, and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
  • Pinto JA; Federal University of Minas Gerais, Belo Horizonte, Brazil.
  • Dobbels EFM; Stellenbosch University, Stellenbosch, South Africa.
  • Archary M; CAPRISA Umlazi CTU, Durban, South Africa.
  • Chokephaibulkit K; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Ounchanum P; Chiang Rai Prachanukroh Hospital, Chiang Rai, Thailand.
  • Deville JG; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
  • Hazra R; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
  • Townley E; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Wiznia A; Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York, NY, USA.
Lancet HIV ; 9(5): e332-e340, 2022 05.
Article em En | MEDLINE | ID: mdl-35489377
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Inibidores de Integrase de HIV Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Soropositividade para HIV / Inibidores de Integrase de HIV Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda